Skip to main content
TipRanks
Go Ultimate75% OFF

PDS Biotechnology (EU6) Income Statement

2 Followers

PDS Biotechnology Income Statement

Last quarter (Q3 2026), PDS Biotechnology's total revenue was $0.00. In Q3, PDS Biotechnology's net income was $-7.62M. See PDS Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Mar 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ -59.79K$ -57.33K$ 0.00$ 0.00
$ 31.54M$ 36.26M$ 43.05M$ 41.67M$ 21.44M
Depreciation and Amortization$ 21.84K$ 21.11M$ 57.33K$ 86.00$ 5.36K
$ -30.30M$ -12.69M$ -40.08M$ -40.74M$ -21.43M
$ -31.54M$ -36.32M$ -43.05M$ -41.67M$ -21.44M
$ -4.12M$ -2.16M$ -1.30M$ -381.34K$ 4.35K
$ -35.67M$ -38.48M$ -44.35M$ -42.05M$ -21.43M
$ -34.50M$ -37.61M$ -42.94M$ -40.85M$ -16.92M
Per Share Metrics
Basic EPS$ -0.74$ -1.03$ -1.39$ -1.43$ -0.66
Diluted EPS$ -0.74$ -1.03$ -1.39$ -1.43$ -0.66
Weighted Average Shares Outstanding46.38M36.45M30.95M28.60M25.60M
Weighted Average Shares Outstanding (Diluted)46.38M36.45M30.95M28.60M25.60M

Currency in USD

PDS Biotechnology Earnings and Revenue History

-60M-40M-20M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin